Correlation Between Chia and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Chia and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chia and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chia and Inhibikase Therapeutics, you can compare the effects of market volatilities on Chia and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chia with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chia and Inhibikase Therapeutics.
Diversification Opportunities for Chia and Inhibikase Therapeutics
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Chia and Inhibikase is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Chia and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Chia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chia are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Chia i.e., Chia and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Chia and Inhibikase Therapeutics
Assuming the 90 days trading horizon Chia is expected to generate 0.87 times more return on investment than Inhibikase Therapeutics. However, Chia is 1.14 times less risky than Inhibikase Therapeutics. It trades about -0.19 of its potential returns per unit of risk. Inhibikase Therapeutics is currently generating about -0.32 per unit of risk. If you would invest 2,388 in Chia on November 2, 2024 and sell it today you would lose (648.00) from holding Chia or give up 27.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 90.48% |
| Values | Daily Returns |
Chia vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Chia |
| Inhibikase Therapeutics |
Chia and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chia and Inhibikase Therapeutics
The main advantage of trading using opposite Chia and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chia position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.The idea behind Chia and Inhibikase Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |